Skip to content

Join our community and subscribe to our free weekly newsletter

Subscribe
  • Latest News
    • Articles
    • Live Talks
    • Trials Update
  • Prevention & Risk Factors
    • Science-Backed Dementia Prevention
    • Alzheimer’s Genetics & Risk Factors
    • Menopause
    • Long COVID
  • Dementias
    • Alzheimer’s Disease
    • Vascular Dementia
    • Frontotemporal Dementia (FTD)
    • Lewy Body Dementia
    • Traumatic Brain Injury & CTE
  • Brain Disorders
    • Mild Cognitive Impairment (MCI)
    • Parkinson’s Disease
  • Getting Diagnosed
    • Diagnosis
    • Journey to Diagnosis
    • Genetic Testing
    • Alzheimer’s Biomarkers
    • Diversity and Dementia
  • Caregivers
    • Caregiver Voices
  • Learning Guides

Latest news

  • brain energy

    The Link Between Energy Deficiency in the Brain and Alzheimer’s

  • donanemab treatment, David Weidman

    Meet Lilly’s Investigational Alzheimer’s Drug Donanemab: A Q&A With Dr. David Weidman

  • unqualified caregivers, grey market

    1/3 of Families May Be Hiring Unqualified Caregivers

  • blood-brain barrier aging, daniela kaufer, blood-brain barrier

    Neuroscientist Daniela Kaufer: Aging, Disease, and the Blood-Brain Barrier

  • hearing impairment dementia, danielle powell, hearing loss

    Audiologist Danielle Powell: Navigating Hearing Loss in Aging and Dementia

  • aduhelm declined, aducanumab

    Some Hospitals Refuse to Offer Alzheimer’s Drug Aduhelm

  • Jalisco mutation, Andres Martin, alzheimer's

    The Jalisco Gene: A Military Pilot’s Story

  • amyloid hypothesis, beta-amyloid peptide, amyloid plaques

    Amyloid Hypothesis Twist: Restoring ‘Good’ Beta-Amyloid to Treat Alzheimer’s

  • Will Medicare cover Alzheimer's drugs like Aduhelm? An analysis and decision-making process is underway.

    Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow

  • aduhelm drug, aducanumab, alzheimer's treatment - fda aduhelm investigation

    FDA Head Calls for Investigation Into Controversial Aduhelm Approval

  • aduhelm label, aducanumab

    FDA Limits the Use of Aduhelm After Criticisms of Broad Approval

  • Lynn Casteel Harper

    Lynn Casteel Harper: Suffering No More—Reimagining Dementia for a Post-COVID World

  • AI for alzheimer's, darmiyan, brainsee

    A Virtual Microscope for Alzheimer’s Earns FDA ‘Breakthrough’ Designation

  • exercise nursing home, long-term care, walking

    Improving Health and Quality of Life for Long-Term Care Residents: Sit Less, Move More

  • home modifications aging, aging in place, older adults

    Aging in Place: Modifications for Safer Homes

Previous798081Next

Sign up for our weekly newsletter

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

Sign Up

Copyright © 2026 Being Patient

Join Our Community

Get brain health and dementia news, storytelling, and expert insights right to your inbox. Sign up for our free weekly newsletter.

You're in! Thanks for subscribing — our free weekly newsletter is coming your way.
You’re already subscribed to our newsletter.

About Being Patient

  • Advisors
  • Contribute
  • About Us
  • Partnerships
  • Contact Us
  • Press
  • Glossary

Legal

  • Terms & Conditions
  • Privacy Policy
  • AI Policy
  • Republishing Our Content
Copyright © 2026 Being Patient

Social Media

  • Instagram 
  • Facebook
  • LinkedIn
  • YouTube
  • TikTok
  • X
Copyright © 2026 Being Patient

Page load link
Go to Top